"Buy Peptides from South Africa's Most Trusted Source - Free Delivery Over R 2500"

GLP-1

R750.00

Lower blood sugar levels, enhance insulin secretion, improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Decrease appetite by delaying gastric emptying and reducing intestinal motility. Reduce weight gain

Share:
SKU: d1e6483e494a-1-2-1-3 Category: Tags: , ,

Scientific Name:GLP-1 (Glucagon-like peptide-1)
Clinical Test Expectation:Lower blood sugar levels, treats type 2 diabetes, enhance insulin secretion, improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimer’s disease. Decrease appetite by delaying gastric emptying and reducing intestinal motility. Reduce weight gain
MG Strength:  3 mg per vial

Detailed Product Information

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a group of drugs used to treat type 2 diabetes. GLP-1 RAs are very effective at lowering blood sugar levels. As an added bonus, some have also shown benefits for heart health and kidney function.

Some people may be better suited to treatment with GLP-1 RAs than others.

The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion

There’s a class of type 2 diabetes drugs that not only improves blood sugar control but may also lead to weight loss. This class of drugs is commonly called glucagon-like peptide 1 (GLP-1) agonists. Another class of medications associated with weight loss and improved blood sugar control is the sodium glucose cotransporter 2 (SGLT-2) inhibitors. These include canagliflozin (Invokana), dapagliflozin (Farxiga) and empagliflozin (Jardiance).

Weight loss can vary depending on which GLP-1 medication you use and your dose. But weight loss may average about 3 to 5.5 pounds (1.5 to 2.5 kilograms, or kg) when using these drugs.

If you’re actively trying to lose weight through lifestyle changes and add the use of one of these medications, research has shown that the drugs may lead to around 6 to 9 pounds (2.8 to 4.2 kg) of additional weight loss.

Diabetes drugs in the GLP-1 agonists class include:

  • Dulaglutide (Trulicity), taken by injection weekly
  • Exenatide extended release (Bydureon), taken by injection weekly
  • Exenatide (Byetta), taken by injection twice daily
  • Semaglutide (Ozempic), taken by injection weekly
  • Semaglutide (Rybelsus), taken by mouth once daily
  • Liraglutide (Victoza), taken by injection daily
  • Lixisenatide (Adlyxin), taken by injection daily

These medications mimic the action of a hormone called glucagon-like peptide 1. When blood sugar levels start to rise after someone eats, these drugs stimulate the body to secrete more insulin. The extra insulin helps lower blood sugar levels.

Lower blood sugar levels are helpful for controlling type 2 diabetes, but it’s not exactly clear how the GLP-1 drugs lead to weight loss. Doctors do know that GLP-1s appear to help suppress appetite. These drugs also slow the movement of food from the stomach into the small intestine. As a result, you may feel full faster and longer, so you eat less.

Along with helping to control blood sugar and boost weight loss, GLP-1s and SGLT-2 inhibitors seem to have other significant benefits. Research has found that some drugs in these classes of medications may lower the risk of heart disease, including heart failure; stroke; and kidney disease. People taking these drugs have seen improvements in their blood pressure and cholesterol levels, though it’s not clear whether these benefits are from the medication or the weight loss.

The downside to GLP-1 drugs is that all but one has to be taken by injection. And, like any medication, there is a risk of side effects, some serious. More common side effects usually improve after you’ve taken the medication for a while.

Some of the more common side effects include:

  • Nausea
  • Vomiting
  • Diarrhea

Low blood sugar levels (hypoglycemia) are a more serious risk linked to the GLP-1 class of medications. But the risk of low blood sugar levels is usually only increased if you’re taking another medication known to lower blood sugar at the same time, such as sulfonylureas or insulin.

The GLP-1 class of drugs isn’t recommended if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia. Laboratory studies have linked these drugs with thyroid tumors in rats, but until more long-term studies are completed, the risk to humans isn’t known. They’re also not recommended if you’ve had pancreatitis.

The drugs already discussed are designed for people who have type 2 diabetes. There is also a drug that contains a higher dose of liraglutide (Saxenda) that’s approved for the treatment of obesity in people who don’t have diabetes.

If you have diabetes and wonder if one of these drugs may be helpful for you, talk to your doctor.

Source : https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/expert-answers/byetta/faq-20057955

Mixing and our recommended dosage

STARTING DOSE : You inject 3ml water into the vial of GLP-1 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 0.75 (3 quarters of syringe) once a week in the morning before breakfast and inject it into the tummy under the skin into the fatty skin layer. A vial should last 4 weeks.

MAINTENANCE DOSE :You inject 1ml water into the vial of GLP-1 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out the entire vial once a week in the morning before breakfast and inject it into the tummy under the skin into the fatty skin layer. A vial should last 1 week.

Additional Information

Read more about our products here : FAQ’s

View more products here : More Products

Affiliate Partner : Visit Now

Mg

2mg